All In Biotech

Free tool

FAERS Monitor: Keppra

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021035 or its brand name (Keppra, Levetiracetam). Reports on generic versions are filed under their own applications.

Reports

133,531

Serious

111,042

83% of reports

Hospitalization

49,622

Death reported

12,023

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure15,769
  • drug ineffective12,490
  • off label use9,614
  • fatigue5,592
  • somnolence4,201
  • epilepsy4,178
  • convulsion3,988
  • maternal exposure during pregnancy3,813
  • fall3,746
  • headache3,723
  • nausea3,627
  • dizziness3,594
  • drug interaction3,507
  • diarrhoea3,280
  • condition aggravated3,250

Reports by year received

View as table
YearReports
2004515
2005758
2006908
20071,182
20081,355
20092,201
20102,447
20113,020
20123,954
20134,020
20144,593
20156,309
20168,121
20177,640
201810,346
201911,939
20209,879
202110,064
20228,884
20239,509
20249,901
20258,886
20267,096

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,920,628 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
epilepsySignal4,17824.824.082,391
seizureSignal15,76924.724.4311,949
convulsionSignal3,98811.711.436,514
maternal exposure during pregnancySignal3,8137.06.818,828
drug interactionSignal3,5073.53.46,289
somnolenceSignal4,2013.33.26,787
fall3,7461.81.71,290
off label use9,6141.71.73,105
condition aggravated3,2501.71.6921
drug ineffective12,4901.51.52,181
dizziness3,5941.11.159
fatigue5,5921.11.189
headache3,7230.90.917
diarrhoea3,2800.80.8169
nausea3,6270.70.7406

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.